SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-134752
Filing Date
2020-12-11
Accepted
2020-12-11 16:01:28
Documents
13
Period of Report
2020-12-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2038272d1_8k.htm   iXBRL 8-K 28916
2 EXHIBIT 3.1 tm2038272d1_ex3-1.htm EX-3.1 125603
  Complete submission text file 0001104659-20-134752.txt   365566

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rytm-20201209.xsd EX-101.SCH 3186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20201209_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20201209_pre.xml EX-101.PRE 22710
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2038272d1_8k_htm.xml XML 3836
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 201383580
SIC: 2834 Pharmaceutical Preparations